Related Experiment Video
Updated: Jul 26, 2026

Retro-orbital Injection in Adult Zebrafish
Published on: December 7, 2009
Rhabdomyosarcoma of the orbit in a four months old infant in Zimbabwe: A case report
I Chitsike1, R Masanganise, D Sibanda
1Department of Paediatrics and Child Health, University of Zimbabwe, College of Health Sciences, P.O. Box A 178, Avondale, Harare, Zimbabwe.
Insights
Infants with rhabdomyosarcoma have a poorer prognosis due to local failure. Aggressive treatment and optimal chemotherapy are crucial for better outcomes in infant rhabdomyosarcoma.
Area of Science:
- Pediatric Oncology
- Cancer Research
Background:
- Rhabdomyosarcoma presents a significant challenge in infants, often associated with poorer prognoses compared to older children.
- High rates of local failure contribute to adverse outcomes in infant rhabdomyosarcoma cases.
Observation:
- This report details a 4-month-old infant diagnosed with orbital rhabdomyosarcoma, experiencing a poor outcome.
- The case highlights challenges in managing infant rhabdomyosarcoma, including reluctance towards aggressive local control and suboptimal chemotherapy.
Findings:
- Infants with rhabdomyosarcoma face worse prognoses, largely due to difficulties in achieving local disease control.
- Suboptimal chemotherapy dosing and hesitation in employing aggressive local therapies are identified as key factors impacting infant outcomes.
Implications:
- Further research is essential to establish effective and appropriate local therapeutic strategies for infants diagnosed with rhabdomyosarcoma.
- Optimizing chemotherapy regimens and local control measures are critical for improving survival rates in this vulnerable population.
Abstract:
Infants younger than one year of age with Rhabdomyosarcoma appear to have worse prognosis compared to older children due partly to high rates of local failure. We report a 4 months old infant with orbital rhabdomyosarcoma with poor outcome. Reluctance to use aggressive local control measures and suboptimal chemotherapy dosing are significant contributory factors. Call is made for need for more studies to determine appropriate local therapy in infants with rhabdomyosarcoma.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

